BLCO · Bausch & Lomb Corp · Webcasts, Transcripts & Audio
$21.09
-0.05 (-0.24%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$7.54B
Shares
357.50M
Volume · Nov 13
525.95K
Avg daily vol (3M)
638.53K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Bausch & Lomb Corp Webcasts
Earnings calls, investor updates, investor days and conferences for Bausch & Lomb Corp (BLCO), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-10-28
Bausch & Lomb Corp (BLCO) Q3 2026 Earnings Call Transcript
Confident tone
Margin expansion and operating leverage
Innovation pipeline and capital allocation
Consumer and dry eye portfolio
Revenue
$1.38B
▲ 7.3% YoY Diluted EPS
$0.09
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-07-29
Bausch & Lomb Corp (BLCO) Q2 2026 Earnings Call Transcript
Confident tone
Pharmaceuticals (MIBO/Miebo and Zydra)
Cash flow and balance sheet / leverage
Revenue and EBITDA growth
Revenue
$1.39B
▲ 9.1% YoY Diluted EPS
$-0.04
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-04-29
Bausch & Lomb Corp (BLCO) Q1 2026 Earnings Call Transcript
Confident tone
Leverage and investor returns
Pharmaceuticals strength
Surgical business reset
Revenue
$1.24B
▲ 9.4% YoY Diluted EPS
$-0.20
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-18
Bausch & Lomb Corp (BLCO) Q4 2025 Earnings Call Transcript
Confident tone
Consumer franchise (LUMIFY, PreserVision)
Pipeline and R&D
Dry eye portfolio (Miebo, Blink)
Revenue
$1.41B*
▲ 9.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-29
Bausch & Lomb Corp (BLCO) Q3 2025 Earnings Call Transcript
Positive tone
Pharmaceuticals / Miebo performance
Investor Day and 3-year plan
Surgical / IOL recovery
Revenue
$1.28B
▲ 7.1% YoY Diluted EPS
$-0.08
▼ 900% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-30
Bausch & Lomb Corp (BLCO) Q2 2025 Earnings Call Transcript
Positive tone
Dry eye portfolio growth
enVista IOL recall recovery
Consumer / LUMIFY performance
Revenue
$1.28B
▲ 5.1% YoY Diluted EPS
$-0.18
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-30
Bausch & Lomb Corp (BLCO) Q1 2025 Earnings Call Transcript
Positive tone
enVista IOL voluntary recall and recovery
2025 guidance and outlook
Vision Care / contact lens growth
Revenue
$1.14B
▲ 3.5% YoY Diluted EPS
$-0.60
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-19
Bausch & Lomb Corp (BLCO) Q4 2024 Earnings Call Transcript
Revenue
$1.28B*
▲ 9.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-30
Bausch & Lomb Corp (BLCO) Q3 2024 Earnings Call Transcript
Confident tone
Pharmaceutical segment (Miebo, Xiidra)
Execution and revenue growth momentum
Product launch cycle and launches
Revenue
$1.20B
▲ 18.8% YoY Diluted EPS
$0.01
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-31
Bausch & Lomb Corp (BLCO) Q2 2024 Earnings Call Transcript
Confident tone
Pharmaceuticals / MIEBO
Innovation and Product Launches
Constant Currency Revenue Growth
Revenue
$1.22B
▲ 17.5% YoY Diluted EPS
$-0.43
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
Bausch & Lomb Corp (BLCO) Q1 2024 Earnings Call Transcript
Confident tone
Innovation pipeline and product launches
Miebo (dry eye) launch and reimbursement coverage
Revenue growth and segment performance
Revenue
$1.10B
▲ 18% YoY Diluted EPS
$-0.48
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-21
Bausch & Lomb Corp (BLCO) Q4 2023 Earnings Call Transcript
Confident tone
Dry Eye Franchise (Miebo and Xiidra)
2024 Product Launches
Margin Expansion Guidance
Revenue
$1.17B*
▲ 17.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-01
Bausch & Lomb Corp (BLCO) Q3 2023 Earnings Call Transcript
Revenue
$1.01B
▲ 6.9% YoY Diluted EPS
$-0.24
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
Bausch & Lomb Corp (BLCO) Q2 2023 Earnings Call Transcript
Revenue
$1.03B
▲ 10% YoY Diluted EPS
$-0.09
▼ 1000% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
Bausch & Lomb Corp (BLCO) Q1 2023 Earnings Call Transcript
Revenue
$931.00M
▲ 4.7% YoY Diluted EPS
$-0.26
▼ 533.3% YoY
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-22
Bausch & Lomb Corp (BLCO) Q4 2022 Earnings Call Transcript
Revenue
$996.00M*
▼ 0.5% YoY
Rev · 6q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Bausch & Lomb Corp (BLCO) Q3 2022 Earnings Call Transcript
Revenue
$942.00M
▼ 0.7% YoY Diluted EPS
$-0.05
▼ 129.4% YoY
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Bausch & Lomb Corp (BLCO) Q2 2022 Earnings Call Transcript
Revenue
$941.00M
▲ 0.7% YoY Diluted EPS
$0.01
▼ 92.3% YoY
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-06-08
Bausch & Lomb Corp (BLCO) Q1 2022 Earnings Call Transcript
Revenue
$889.00M
▲ 0.9% YoY Diluted EPS
$0.06
▼ 25% YoY
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–19 of 19 webcasts
Key facts
CIK
1860742
CUSIP
071705107
13F (30d)
68 filings
65 filers
Visit website
Investor relations